Chromium picolinate is backed by over 10 years of research. Its quality, safety and effectiveness have been demonstrated in studies carried out by leading scientists at respected hospitals, universities and research centers. Overall, chromium picolinate has been tested in over 50 clinical studies involving over 3,000 participants.
As the body of clinical evidence continues to build, the link between chromium and insulin health has become increasingly important to metabolic research.
Many scientists now believe that chromium supplementation may be important to managing the health of people at risk for insulin resistance.
Insulin resistance can lead to diabetes, cardiovascular disease (CVD), obesity and other chronic health conditions.
The attached clinical research summaries shed light on chromium picolinate’s beneficial role in: